# Osprey Bitcoin Trust: financial statements, quarterly

OBTC · Nasdaq · CIK 1767057 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/obtc.md) · [Financials](/companies/obtc/financials.md) · [Filings](/companies/obtc/filings.md) · [Insiders](/companies/obtc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/obtc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2022-09-30) | Q3 FY2024 (2023-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [1.5](/filings/0001493152-23-039256.md) | [(9.7)](/filings/0001493152-23-039256.md) | [(21.7)](/filings/0001493152-26-022790.md) | [48.3](/filings/0001493152-26-037040.md) | [(21.8)](/filings/0001493152-26-022790.md) | [(8.8)](/filings/0001493152-26-037040.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2021-12-31) | period not labelled (2022-03-31) | period not labelled (2022-06-30) | period not labelled (2022-09-30) | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2024 (2023-09-30) | period not labelled (2024-12-31) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0000930413-23-001072.md) | [0.0](/filings/0000930413-22-001053.md) | [0.0](/filings/0000930413-22-001454.md) | [0.0](/filings/0000930413-22-001932.md) | [0.0](/filings/0001493152-23-039256.md) | not reported | [0.0](/filings/0000930413-23-001940.md) | [0.0](/filings/0001493152-23-039256.md) | [0.0](/filings/0001493152-26-014439.md) | [0.1](/filings/0001493152-26-037040.md) | [0.0](/filings/0001493152-26-022790.md) | [0.0](/filings/0001493152-26-037040.md) |
| Total assets | $m | [130](/filings/0000930413-23-001072.md) | [129](/filings/0000930413-22-001053.md) | [53.2](/filings/0000930413-22-001454.md) | [54.7](/filings/0000930413-22-001932.md) | [46.3](/filings/0001493152-23-039256.md) | [79.3](/filings/0000930413-23-001597.md) | [84.1](/filings/0000930413-23-001940.md) | [74.4](/filings/0001493152-23-039256.md) | [181](/filings/0001493152-26-014439.md) | [137](/filings/0001493152-26-037040.md) | [64.2](/filings/0001493152-26-022790.md) | [55.4](/filings/0001493152-26-037040.md) |
| Total liabilities | $m | [0.1](/filings/0000930413-23-001072.md) | [0.1](/filings/0000930413-22-001053.md) | [0.2](/filings/0000930413-22-001454.md) | [0.1](/filings/0000930413-22-001932.md) | [0.3](/filings/0001493152-23-039256.md) | [0.3](/filings/0000930413-23-001597.md) | [0.1](/filings/0000930413-23-001940.md) | [0.1](/filings/0001493152-23-039256.md) | [0.3](/filings/0001493152-26-014439.md) | [0.1](/filings/0001493152-26-037040.md) | [0.0](/filings/0001493152-26-022790.md) | [0.0](/filings/0001493152-26-037040.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

Shares outstanding: 2,940,535 at 2026-06-30, from the cover of the [10-Q filed 2026-08-11](/filings/0001493152-26-037040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.